Frank Holler, Director
Frank Holler is an active investor and successful entrepreneur. He previously served as President & CEO of Xenon Pharmaceuticals Inc.; President & CEO of ID Biomedical Corporation; and as a founding director of Angiotech Pharmaceuticals.

   
Dr. Avtar Dhillon, Director
Dr. Avtar Dhillon is the Executive Chairman of Inovio Biomedical. Prior to joining Inovio, Dr. Dhillon was Vice President of MDS Capital Corp., one of North America’s leading healthcare venture capital organizations.
   
Jim Heppell, Director

Jim Heppell has acted as a director, officer or advisor to many life science companies.  He was previously a corporate finance lawyer with the law firms Russell & DuMoulin and Catalyst Corporate Finance Lawyers (both firms now part of Fasken Martineau).

 

Bob Rieder , Director

Bob Rieder has extensive experience in venture capital investing and in operation management. He has been Executive Chairman of Cardiome Pharma (TSX: COM; NASDAQ:SRME) since April 2009 and was previously President and CEO of Cardiome since 1998.  Prior to joining Cardiome, he was Vice-President at MDS Ventures Pacific Inc., the Vancouver-based affiliate of MDS Capital Corp., and has served as a director for nine public and private technology companies.